The Science still makes sense and the trials carried out so far...

The Science still makes sense and the trials carried out so far do seem to suggest PBT2 does do something
Dementia is an issue that is simply to big to ignore
So
If the FDA ruling was infact questionable then there is every possibility the Europeans will approve PBT2 for testing over there which i believe is a bigger market anyway? If the FDA ruling was based on real issues then the EMA will not approve it over there so - See what happens, its all any of us can really do under the circumstances

Also if PBT2 does get up in Europe and it works then its just a matter of time before the FDA will reverse its decision and approve PBT2 in the US as well.

My only concern is will all this happen before I am an old man in which case the drug may come in handy but the dollars may not be as much fun

As for competition, yes that is always a possibility, but so far for all the noise no new drug is to my knowledge on Market yet

All my Opinion etc.